CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Cash flows from operating activities:
Net income	$ 12,357	$ 35,134
Adjustments to reconcile net income to net cash (used in)/provided by operating activities:
Depreciation and amortization	6,960	7,278
Transactional losses	594	204
Provision for inventories and accounts receivable	4,489	3,803
Deferred income taxes	(1,582)	(2,032)
Stock-based compensation	4,094	5,529
Other	265	754
Changes in assets and liabilities:
Trade receivables	(37,026)	(42,027)
Inventories	(24,697)	10,758
Other current assets	(4,675)	4,107
Accounts payable	(3,709)	(7,492)
Accrued liabilities	11,974	12,336
Accrued payroll and benefits	4,994	(7,039)
Income taxes receivable	8,374	(4,494)
Income taxes payable	(19,855)	(10,014)
Other non-current assets	(3,141)	1,293
Other non-current liabilities	(43)	(730)
Net cash (used in)/provided by operating activities	(40,627)	7,368
Cash flows from investing activities:
Capital expenditures	(6,368)	(6,627)
Long-term investments	(5,467)	(2,040)
Trademarks and other intangibles	(86)	(113)
Net cash used in investing activities	(11,921)	(8,780)
Cash flows from financing activities:
Dividends paid	(23,319)	(45,399)
Stock repurchases	(2,628)	(2,349)
Distribution of noncontrolling interest earnings	0	(780)
Stock awards and options exercised and other changes	(1,101)	(73)
Net cash used in financing activities	(27,048)	(48,601)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(917)	(377)
Net decrease in cash, cash equivalents and restricted cash	(80,513)	(50,390)
Cash, cash equivalents, and restricted cash at beginning of year	262,814	252,179
Cash, cash equivalents, and restricted cash at end of period	182,301	201,789
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	181,548	200,965
Restricted cash included in other non-current assets	753	824
Cash, cash equivalents, and restricted cash at end of period	$ 182,301	$ 201,789